Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Bullboard Posts
Comment by retiredcopon May 08, 2018 7:42pm
126 Views
Post# 28001297

RE:RE:RE:RE:Support from Within

RE:RE:RE:RE:Support from Within First thing silentrunning is .what maybe gets under people’s skin is occasionally you comment with very poorly researched info..if you did your research you would see that dr Cashman has millions of shares in this ( HIS) company...he does not take pay from the company he started ...he is well compensated by his internationally recognized medical clinic at UBC...and he has numerous scientists and researchers working under his supervision ..and probabaly if you had the opportunity talk,to,him you would find that his goal is to come up,with solutions to many of the worst diseases out there and the financial outcome of the company Is secondary..he Is  pretty satisfied with the number of shares he holds..and if the company goes under...he will be the only one that would come out if this ahead....he I sent listed on almost all the patents that PMN (AMF) has......and you should feel privileged that you had a comment from Luxor...he does not speak often but he has forgotten more about this company than any of us even know , so my suggestion is take his comments very seriously because he does not post often...and inregards to the insider buying...their actions are a great indicator that there is  high confidence in what is transpiring and the future looks very positive.....sort of a signal to many on what’s happening behind the scenes...
Bullboard Posts